AN2 Therapeutics, Inc. (ANTX) SEC filings
ANTX SEC filings moved a median of 0.00% by the close. ANTX SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the ANTX overview →
58 measured ANTX SEC filing events.
Where these ANTX SEC filings landedvs 56 measured ANTX SEC filing reactions
| Middle 50% of ANTX SEC filing reactions | -2.91% to +3.15% |
|---|---|
| Median reaction (to close) | 0.00% |
| Measured reactions | 56 |
Point-in-time · zero look-ahead
Half of the 56 ANTX SEC filing events with a measured close landed between -2.91% and +3.15%; 48% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form S-8 AN2 Therapeutics, Inc. | SEC filing · Form S-8 | +0.00% | -1.29% | |
| Form 10-Q AN2 Therapeutics, Inc. For: Jun 30 | SEC filing · Form 10-Q | +10.92% | +3.12% | |
| Form 8-K AN2 Therapeutics, Inc. For: Aug 11 | SEC filing · Form 8-K | +10.92% | +3.12% | |
| Form 8-K AN2 Therapeutics, Inc. For: Jun 03 | SEC filing · Form 8-K | -0.26% | +2.63% | |
| Form 8-K AN2 Therapeutics, Inc. For: Jun 04 | SEC filing · Form 8-K | -1.55% | -8.83% | |
| Form 10-Q AN2 Therapeutics, Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.66% | -6.77% | |
| Form 8-K AN2 Therapeutics, Inc. For: May 11 | SEC filing · Form 8-K | +0.66% | -6.77% | |
| Form ARS AN2 Therapeutics, Inc. For: Dec 31 | SEC filing · Form ARS | +0.25% | +7.27% | |
| Form DEF 14A AN2 Therapeutics, Inc. For: Apr 22 | SEC filing · Form DEF | +0.25% | +7.27% | |
| Form DEFA14A AN2 Therapeutics, Inc. | SEC filing · Form DEFA14A | +0.25% | +7.27% | |
| Form EFFECT AN2 Therapeutics, Inc. | SEC filing · Form EFFECT | +0.00% | +6.14% | |
| Form 8-K AN2 Therapeutics, Inc. For: Apr 09 | SEC filing · Form 8-K | +0.67% | -1.00% | |
| Form S-3 AN2 Therapeutics, Inc. | SEC filing · Form S-3 | +0.67% | -1.00% | |
| Form D AN2 Therapeutics, Inc. | SEC filing · Form D | +3.00% | -1.37% | |
| Form 8-K AN2 Therapeutics, Inc. For: Mar 19 | SEC filing · Form 8-K | +0.26% | -1.03% | |
| Form 10-K AN2 Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-K | +0.62% | -4.74% | |
| Form 8-K AN2 Therapeutics, Inc. For: Mar 17 | SEC filing · Form 8-K | +0.62% | -4.74% | |
| Form S-8 AN2 Therapeutics, Inc. | SEC filing · Form S-8 | +0.62% | -4.74% | |
| Form 8-K AN2 Therapeutics, Inc. For: Mar 08 | SEC filing · Form 8-K | +3.83% | +16.17% | |
| Form 8-K AN2 Therapeutics, Inc. For: Jan 26 | SEC filing · Form 8-K | +0.00% | +0.00% | |
| Form 10-Q AN2 Therapeutics, Inc. For: Sep 30 | SEC filing · Form 10-Q | +0.00% | — | |
| Form 8-K AN2 Therapeutics, Inc. For: Nov 12 | SEC filing · Form 8-K | +0.00% | — | |
| Form 10-Q AN2 Therapeutics, Inc. For: Jun 30 | SEC filing · Form 10-Q | +0.47% | -0.94% | |
| Form 8-K AN2 Therapeutics, Inc. For: Aug 12 | SEC filing · Form 8-K | +0.47% | -0.94% | |
| Form 8-K AN2 Therapeutics, Inc. For: Jun 17 | SEC filing · Form 8-K | +0.00% | -0.90% | |
| Form 8-K AN2 Therapeutics, Inc. For: Jun 11 | SEC filing · Form 8-K | +0.00% | +0.89% | |
| Form 8-K AN2 Therapeutics, Inc. For: May 22 | SEC filing · Form 8-K | +0.00% | +0.00% | |
| Form 10-Q AN2 Therapeutics, Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.86% | +2.59% | |
| Form 8-K AN2 Therapeutics, Inc. For: May 13 | SEC filing · Form 8-K | +0.86% | +2.59% | |
| Form 8-K AN2 Therapeutics, Inc. For: May 01 | SEC filing · Form 8-K | +8.11% | +9.91% | |
| Form ARS AN2 Therapeutics, Inc. For: Dec 31 | SEC filing · Form ARS | +0.00% | +3.23% | |
| Form DEF 14A AN2 Therapeutics, Inc. For: Apr 10 | SEC filing · Form DEF | +0.00% | +3.23% | |
| Form DEFA14A AN2 Therapeutics, Inc. | SEC filing · Form DEFA14A | +0.00% | +3.23% | |
| Form 10-K AN2 Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-K | -7.92% | +2.01% | |
| Form 8-K AN2 Therapeutics, Inc. For: Mar 25 | SEC filing · Form 8-K | -7.92% | +2.01% | |
| Form S-8 AN2 Therapeutics, Inc. | SEC filing · Form S-8 | -7.92% | +2.01% | |
| Form 10-Q AN2 Therapeutics, Inc. For: Sep 30 | SEC filing · Form 10-Q | -3.17% | -2.91% | |
| Form 8-K AN2 Therapeutics, Inc. For: Nov 13 | SEC filing · Form 8-K | -3.17% | -2.91% | |
| Form 8-K AN2 Therapeutics, Inc. For: Nov 04 | SEC filing · Form 8-K | +0.01% | +0.00% | |
| Form 8-A12B AN2 Therapeutics, Inc. | SEC filing · Form 8-A12B | +4.21% | +9.42% | |
| Form 8-K AN2 Therapeutics, Inc. For: Aug 15 | SEC filing · Form 8-K | +4.21% | +9.42% | |
| Form 10-Q AN2 Therapeutics, Inc. For: Jun 30 | SEC filing · Form 10-Q | +0.00% | -1.87% | |
| Form 8-K AN2 Therapeutics, Inc. For: Aug 13 | SEC filing · Form 8-K | +0.00% | -1.87% | |
| Form 8-K AN2 Therapeutics, Inc. For: Aug 07 | SEC filing · Form 8-K | -32.28% | -34.81% | |
| Form 8-K AN2 Therapeutics, Inc. For: Jun 19 | SEC filing · Form 8-K | +0.00% | +0.48% | |
| Form 10-K/A AN2 Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-K | +0.00% | -2.99% | |
| Form 10-Q AN2 Therapeutics, Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.00% | -2.99% | |
| Form 8-K AN2 Therapeutics, Inc. For: May 14 | SEC filing · Form 8-K | +0.00% | -2.99% | |
| Form ARS AN2 Therapeutics, Inc. For: Dec 31 | SEC filing · Form ARS | +0.00% | +1.28% | |
| Form DEF 14A AN2 Therapeutics, Inc. For: Jun 19 | SEC filing · Form DEF | +0.00% | +1.28% | |
| Form DEFA14A AN2 Therapeutics, Inc. | SEC filing · Form DEFA14A | +0.00% | +1.28% | |
| Form PRE 14A AN2 Therapeutics, Inc. For: Jun 19 | SEC filing · Form PRE | +0.00% | -2.90% | |
| Form 10-K AN2 Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-K | +1.76% | +10.26% | |
| Form S-8 AN2 Therapeutics, Inc. | SEC filing · Form S-8 | +1.76% | +10.26% | |
| Form 8-K AN2 Therapeutics, Inc. For: Mar 28 | SEC filing · Form 8-K | +1.76% | +10.26% | |
| Form 8-K AN2 Therapeutics, Inc. For: Feb 12 | SEC filing · Form 8-K | -3.74% | -4.49% | |
| Form 10-Q AN2 Therapeutics, Inc. For: Sep 30 | SEC filing · Form 10-Q | +0.00% | -7.92% | |
| Form 8-K AN2 Therapeutics, Inc. For: Nov 09 | SEC filing · Form 8-K | +0.00% | -7.92% |
Keep exploring
More ANTX: earnings → · analyst actions → · ANTX overview →